Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Asset Writedowns and Impairment (2024 - 2025)

Glaukos (GKOS) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $105.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $105.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $112.9 million, a N/A change, with the full-year FY2025 number at $112.9 million, up 124129.67% from a year prior.
  • Asset Writedowns and Impairment was $105.8 million for Q4 2025 at Glaukos, up from $3.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $105.8 million in Q4 2025 to a low of -$248000.0 in Q2 2024.